Opioids: Supervised Injection Facilities

New England CEPAC

ICER will assess the comparative clinical effectiveness and economic value of supervised injection facilities (SIFs). ICER has reviewed other related topics, such as abuse-deterrent opioid formulations, medication-assisted treatment for opioid use disorder, and non-drug interventions for lower back pain.

This review reinforces ICER’s commitment to provide an independent evaluation of the evidence around interventions that target the public health crises stemming from the opioid epidemic in the United States.

Review date: December 2020 

For more information, please contact Catherine Koola, Program Manager, at ckoola@icer-review.org.

Associated Meetings

December 3, 2020 9:30 AM - 4 PM ET

Key Dates

Associated Materials

02/21/2020

05/19/2020

05/19/2020 – 06/09/2020

05/19/2020

06/17/2020

07/21/2020

08/13/2020

09/24/2020
Draft Evidence Report

09/24/2020
Draft Voting Questions

09/24/2020
Public Comments

11/13/2020
Revised Voting Questions

11/13/2020
Response to Public Comments

11/13/2020
Meeting Agenda

11/13/2020
Evidence Report

12/03/2020
Evidence Presentation

01/08/2021
Final Evidence Report and Meeting Summary

01/08/2021
Report-at-a-Glance

01/08/2021
Final Policy Recommendations